List of Excipients in API CROFELEMER
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing CROFELEMER
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Napo Pharmaceuticals Inc | MYTESI | crofelemer | 70564-802 | CELLULOSE, MICROCRYSTALLINE | 2031-10-31 |
| Napo Pharmaceuticals Inc | MYTESI | crofelemer | 70564-802 | CROSCARMELLOSE SODIUM | 2031-10-31 |
| Napo Pharmaceuticals Inc | MYTESI | crofelemer | 70564-802 | ETHYL ACRYLATE | 2031-10-31 |
| Napo Pharmaceuticals Inc | MYTESI | crofelemer | 70564-802 | MAGNESIUM STEARATE | 2031-10-31 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for CROFELEMER
Excipient focus: CELLULOSE, MICROCRYSTALLINE
CROFELEMER drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Napo Pharmaceuticals Inc | crofelemer | 70564-802 |
| >Company | >Ingredient | >NDC |
CROFELEMER drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
CROFELEMER drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Napo Pharmaceuticals Inc | crofelemer | 70564-802 |
| >Company | >Ingredient | >NDC |
CROFELEMER drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYL ACRYLATE
CROFELEMER drug variants containing ETHYL ACRYLATE
| Company | Ingredient | NDC |
|---|---|---|
| Napo Pharmaceuticals Inc | crofelemer | 70564-802 |
| >Company | >Ingredient | >NDC |
CROFELEMER drug variants not containing ETHYL ACRYLATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
CROFELEMER drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Napo Pharmaceuticals Inc | crofelemer | 70564-802 |
| >Company | >Ingredient | >NDC |
CROFELEMER drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
CROFELEMER drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Napo Pharmaceuticals Inc | crofelemer | 70564-802 |
| >Company | >Ingredient | >NDC |
CROFELEMER drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
CROFELEMER drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Napo Pharmaceuticals Inc | crofelemer | 70564-802 |
| >Company | >Ingredient | >NDC |
CROFELEMER drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
CROFELEMER drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Napo Pharmaceuticals Inc | crofelemer | 70564-802 |
| >Company | >Ingredient | >NDC |
CROFELEMER drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
CROFELEMER drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Napo Pharmaceuticals Inc | crofelemer | 70564-802 |
| >Company | >Ingredient | >NDC |
CROFELEMER drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
CROFELEMER drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Napo Pharmaceuticals Inc | crofelemer | 70564-802 |
| >Company | >Ingredient | >NDC |
CROFELEMER drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
CROFELEMER drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Napo Pharmaceuticals Inc | crofelemer | 70564-802 |
| >Company | >Ingredient | >NDC |
CROFELEMER drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: XANTHAN GUM
CROFELEMER drug variants containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Napo Pharmaceuticals Inc | crofelemer | 70564-802 |
| >Company | >Ingredient | >NDC |
CROFELEMER drug variants not containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
